Although increased vascularization is probably the response to upregulation of PD-L1 in testicular tumors, the impaired blood–testis barrier has the capacity for an influx of cytotoxic immune cells into tumor tissue but without a chance of efflux, which leads to a reduction in effectiveness of ICI therapy [103]. The gene discussed is CD274; the disease is neoplasm.